Preview

Meditsinskiy sovet = Medical Council

Advanced search

Study of skin microbiota in patients with chronic lichenoid parapsoriasis

https://doi.org/10.21518/ms2025-014

Abstract

Introduction. The article presents the results of a study of differences in the skin microbiota of patients with PLC compared with healthy individuals.

Aim. To study the composition of the skin microbiota in patients with chronic lichenoid pityriasis compared with healthy individuals.

Materials and methods. The objects of the study were 30 patients with PLC and 30 patients with PLEVA, who were under observation in the dermatological hospital department of the State Budgetary Institution of Healthcare in Ufa (comparison group – 30 healthy individuals). All participants were examined and clinically examined by a dermatovenereologist with the clarification of anamnestic data, determination of the form of the PL.

Results. Were examined 30 patients with CLP (group 1) and 30 healthy people (group 2). Un sanitized foci of infection (caries, tonsillitis, sinusitis, etc.) were more often detected in group 1 – in 28 (93.3%) vs. 10 (33.3%) individuals in groups 1 and 2 (p < 0.05). The concentration of CIC in group 1 was significantly higher than in the control group (112.2 vs. 54.9 IU/ml, p < 0.05), as well as CD8+ lymphocytes (27.6 vs. 14.0%, p = 0.042). The most common manifestations of the microflora of patients with CLP are Staph. epidermidis (26.6%), Corynebacterium (23.3%) and Candida albicans (26.6%), in the control group – Staph. epidermidis (70.0% of cases), Staph. hominis (30.0%) and Corynebacterium (13.3%).

Conclusion. In patients with lichenoid pityriasis, there is a diversity of the main representatives of the skin microbiota, which has some differences from the microbiota of healthy individuals. There are differences in contamination by various representatives of the microbiome in the affected and intact areas. These data may indicate an association of changes in the skin microbiota in PLC with the progression of the disease and the expression of certain subpopulations of T-lymphocytes.

About the Authors

E. A. Sultanova
Bashkir State Medical University
Russian Federation

Elvira A. Sultanova, Dermatovenerologist, Assistant at the Department of Dermatovenereology

3, Lenin St., Ufa, 450008



E. V. Dvoriankova
Center for Theoretical Problems of Physical and Chemical Pharmacology of Russian Academy of Sciences
Russian Federation

Evgeniya V. Dvoriankova, Dr. Sci. (Med.), Leading Researcher

30, Srednyaya Kalitnikovskaya St., Moscow, 109029



Z. R. Khismatullina
Bashkir State Medical University
Russian Federation

Zarema R. Khismatullina, Dr. Sci. (Med.), Professor, Head of Department of Dermatovenereology

3, Lenin St., Ufa, 450008



K. M. Koreshkova
Bashkir State Medical University
Russian Federation

Ksenia M. Koreshkova, Dermatovenerologist, Associate Professor at the Department of Dermatovenereology

3, Lenin St., Ufa, 450008



M. M. Tuigunov
Bashkir State Medical University
Russian Federation

Marsel M. Tuigunov, Dr. Sci. (Med.), Professor, Head of the Department of Microbiology and Virology

3, Lenin St., Ufa, 450008



References

1. Salava A, Pereira P, Aho V, Väkevä L, Paulin L, Auvinen P et al. Skin Microbiome in Small- and Large-plaque Parapsoriasis. Acta Derm Venereol. 2017;97(6):685–691. https://doi.org/10.2340/00015555-2631.

2. Знаменская ЛФ, Чикин ВВ, Бакулев АЛ, Хойбеш ММ, Олисова ОЮ, Жилова МБ. Федеральные клинические рекомендации по ведению больных псориазом. М.; 2015. Режим доступа: https://www.ismos.ru/guidelines/doc/psoriaz.pdf.

3. Самцов АВ, Белоусова ИЭ, Хайрутдинов ВР. Парапсориазы: клинические рекомендации. 2015. Режим доступа: https://diseases.medelement.com/disease/парапсориазы-рекомендации-рф/15242/.

4. Hapa A, Ersoy-Vans S, Karaduman A. Childhood pityriasis lichenoides andoral erythromycin. Pediatr Dermatol. 2012;29(6):719–724. https://doi.org/10.1111/j.1525-1470.2012.01765.x.

5. Cerf-Bensussan N, Eberl G. The dialog between microbiota and the immune system: shaping the partners through development and evolution. Semin Immunol. 2012;24(1):1–2. https://doi.org/10.1016/j.smim.2011.11.007.

6. Markus JR, Carvalho VO, Lima MN, Abagge KT, Nascimento A, Werner B. The relevance of recognizing clinical and morphologic features of pityriasis lichenoides: clinicopathological study of 29 cases. Dermatol Pract Concept. 2013;3(4):7–10. https://doi.org/10.5826/dpc.0304a02.

7. Avshalumova L, Richardson B, Miller R. Pityriasis lichenoides chronica presenting with bilateral palmoplantar involvement. Cutis. 2016;97(5):345;347;358. Available at: https://pubmed.ncbi.nlm.nih.gov/27274548/.

8. Zang JB, Coates SJ, Huang J, Vonderheid EC, Cohen BA. Pityriasis lichenoides: Long-term follow-up study. Pediatr Dermatol. 2018;35(2):213–219. https://doi.org/10.1111/pde.13396.

9. Jiao L, Liu Y, Xiang X, Xu J, Ma L, Xu ZG. A case of pityriasis lichenoides et varioliformis acuta pemphigoides successfully treated with methotrexate and corticosteroids. Dermatol Ther. 2019;32(4):e12833. https://doi.org/10.1111/dth.12833.

10. Geller L, Antonov NK, Lauren CT, Morel KD, Garzon MC. Pityriasis Lichenoides in Childhood: Review of Clinical Presentation and Treatment Options. Pediatr Dermatol. 2015;32(5):579–592. https://doi.org/10.1111/pde.12581.

11. Chen Y, Zhao M, Xiang X, Wang Z, Xu Z, Ma L. Oral erythromycin in pityriasis lichenoides chronica and pityriasis lichenoides et varioliformis acuta. Dermatol Ther. 2020;33(3):e13311. https://doi.org/10.1111/dth.13311.

12. Oh J, Byrd AL, Deming C, Conlan S, Program NCS, Kong H, Serge JA. Biogeography and individuality shape function in the human skin metagenome. Nature. 2014;514(7520):59–64. https://doi.org/10.1038/nature13786.

13. Egert M, Simmering R. The microbiota of the human skin. Adv Exp Med Biol. 2016;902:61–81. https://doi.org/10.1007/978-3-319-31248-4_5.

14. Nelson KE, Weinstocks GM, Highlander SK, Worley KC, Creasy HH et al. A catalog of reference genomes from the human microbiome. Science. 2010;328(5981):994–999. https://doi.org/10.1126/science.1183605.

15. Krejsgaard T, Willerslev-Olsen A, Lindahl LM, Bonefeld CM, Koralov SB, Geisler C et al. Staphylococcal enterotoxins sti-mulate lymphoma-associated immune dysregulation. Blood. 2014;124(5):761–770. https://doi.org/10.1182/blood-2014-01-551184.

16. Ogrum A, Takci Z, Seckin HY, Cetin E. A case of pityriasis lichenoides: Rapid resolution with azithromycin monotherapy in 3 weeks. Dermatol Ther. 2018;31(5):e12681. https://doi.org/10.1111/dth.12681.

17. Elbendary A, Youssef R, Abdel-Halim MRE, Halim DA, Sharkawy DAE, Alfishawy M et al. Role of streptococcal infection in the etiopathogenesis of pityriasis lichenoides chronica and the therapeutic efficacy of azithromycin: a randomized controlled trial. Arch Dermatol Res. 2023;315(3):521–530. https://doi.org/10.1007/s00403-022-02398-0.

18. Kempf W, Kazakov DV, Palmedo G, Fraitag S, Schaerer L, Kutzner H. Pityriasis lichenoides et varioliformis acuta with numerous CD30(+) cells: a variant mimicking lymphomatoid papulosis and other cutaneous lymphomas. A clinicopathologic, immunohistochemical, and molecular biological study of 13 cases. Am J Surg Pathol. 2012;36(7):1021–1029. https://doi.org/10.1097/PAS.0b013e31824f4f66.

19. Calcaterra V, Cavalli R, Croci GA, Fiori L, Fabiano A, Lunardon L et al. Type D lymphomatoid papulosis with pityriasis lichenoides et varioliformis acutalike features in a child with parvovirus infection: a controversial diagnosis in the spectrum of lymphoid proliferations: case report and literature review. Ital J Pediatr. 2022;48(1):183. https://doi.org/10.1186/s13052-022-01371-x.


Review

For citations:


Sultanova EA, Dvoriankova EV, Khismatullina ZR, Koreshkova KM, Tuigunov MM. Study of skin microbiota in patients with chronic lichenoid parapsoriasis. Meditsinskiy sovet = Medical Council. 2025;(2):16-22. (In Russ.) https://doi.org/10.21518/ms2025-014

Views: 126


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2079-701X (Print)
ISSN 2658-5790 (Online)